T1	intervention 0 16	Dietary flaxseed
T2	eligibility 386 444	postmenopausal patients with newly diagnosed breast cancer
T3	intervention-participants 536 538	19
T4	control 545 562	control (placebo)
T5	control-participants 575 577	13
T7	outcome 960 980	Mean treatment times
T8	cv-cont-mean 986 988	39
T9	iv-cont-mean 993 1000	32 days
T10	outcome 1051 1085	Reductions in Ki-67 labeling index
T11	outcome 1112 1130	c-erbB2 expression
T12	outcome 1169 1178	apoptosis
T16	outcome 1417 1446	mean urinary lignan excretion
T13	outcome 1289 1321	caloric and macronutrient intake
T6	outcome-Measure 706 726	Ki-67 labeling index
T14	outcome-Measure 748 757	apoptosis
T15	outcome-Measure 759 777	c-erbB2 expression
T17	outcome-Measure 783 824	estrogen and progesterone receptor levels
